Short Description Hevolution CEO mobilizing $1 B+/yr for global longevity trials.
Description Former PepsiCo Chief Scientist and Life Biosciences CEO, Dr. Mehmood Khan now leads the Saudi‑backed Hevolution Foundation, which pledges up to $1 billion annually to fund translational aging research. Khan’s focus is accelerating human trials of metformin, rapalogs, and NAD+ boosters in culturally diverse cohorts. He partners with the Buck Institute and Oxford to seed global trial networks and supports WHO engagement on geroscience policy.